Are GLP-1 agonists the answer to our obesity epidemic?

Dapre examines whether GLP-1 agonists are the answer to the obesity epidemic. The number of people living with obesity in the UK has doubled since 1993 and continues to rise. Obesity is associated with various health risks and puts strain on the healthcare system. Current public health initiatives h...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	British journal of general practice 2023-08, Vol.73 (733), p.365-365
1. Verfasser:	Dapre, Elizabeth
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Mellitus, Type 2 Epidemics Glucagon-Like Peptide 1 - agonists Humans Hypoglycemic Agents Life & Times Obesity Obesity - drug therapy Obesity - epidemiology Public health Weight control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!